Neonatal exendin-4 prevents the development of diabetes in the intrauterine growth retarded rat

Diabetes

Volumn 52, Issue 3, 2003, Pages 734-740

  Stoffers, Doris A ^a   Desai, Biva M ^a   DeLeon, Diva D ^a,b   Simmons, Rebecca A ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Ex4, Exendin 4; GLP 1, glucagon like peptide 1; IUGR, intrauterine growth retarded; PD, postnatal day; PDX, pancreatic duodenal homeobox; Ppx, partial pancreatectomy; STZ, streptozotocin

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GLUCOSE HOMEOSTASIS; HUMAN; INTRAUTERINE GROWTH RETARDATION; MORBIDITY; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERINATAL MORBIDITY; PERINATAL MORTALITY; PHENOTYPE; PLACENTA INSUFFICIENCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; BLOOD GLUCOSE; CELL DIFFERENTIATION; CELL DIVISION; DIABETES MELLITUS, TYPE 2; FEMALE; FETAL GROWTH RETARDATION; GENE EXPRESSION; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HOMEODOMAIN PROTEINS; HOMEOSTASIS; ISLETS OF LANGERHANS; PEPTIDES; PLACENTAL INSUFFICIENCY; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANS-ACTIVATORS; VENOMS;

EID: 0037341252     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.3.734     Document Type: Article

References (45)

1. Barker DJP, Osmond C: Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet I:1077-1081, 1986
2. Barker DJP, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM: Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidemia (syndrome X): relation to reduced fetal growth. Diabetologia 36:62-67, 1993
3. Valdez R, Athens MA, Thompson GH, Bradshaw BS, Stern MP: Birthweight and adult health outcomes in a biethnic population in the USA. Diabetologia 37:624-631, 1994
4. Rich-Edwards JW, Colditz GA, Stampfer MJ, Willett WC, Gillman MW, Hennekens CH, Speizer FE, Manson JE: Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med 130:278-284, 1999
5. Hales CN, Barker DJP, Clark PMS, Cox LJ, Fall CH, Osmond C: Fetal and infant growth and impaired glucose tolerance at age 64 years. Br Med J 303:1019-1022, 1991
6. Ravelli G, Stein ZA, Susser MW: Obesity in young men after famine exposure in utero and early infancy. N Engl Med 295:349-354, 1995
7. Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, Ishibashi M, Kageyama R, Guillemot F, Serup P, Madsen OD: Control of endodermal endocrine development by Hes-1. Nat Genet 24:36-44, 2000
8. Hussain MA, Habener JF: Glucagon-like peptide 1 increases glucose-dependent activity of the homeoprotein IDX-1 transactivating domain in pancreatic beta-cells. Biochem Biophys Res Commun 274:616-619, 2000
9. Dutta S, Bonner-Weir S, Montminy M, Wright CV: Regulatory factor linked to late-onset diabetes? Nature 392:560, 1998
10. Jaquet D, Gaboriau A, Czernichow P, Levy-Marchal C: Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. J Clin Endocrlnol Metab 85:1401-1406, 2000
11. McKeigue PM, Lithell HO, Leon DA: Glucose tolerance and resistance to insulin-stimulated glucose uptake in men aged 70 years in relation to size at birth. Diabetologia 41:1133-1138, 1998
12. Van Assche FA, De Prins F, Aerts L, Verjans F: The endocrine pancreas in small-for dates infants. Br j Obstet Gynaecol 84:751-753, 1977
13. Ogata ES, Bussey ME, Finley S: Altered gas exchange, limited glucose and branched chain amino adds, and hypoinsulinism retard fetal growth in the rat. Metabolism 35:970-977, 1986
14. Simmons RA, Gounis AS, Bangalore SA, Ogata ES: Intrauterine growth retardation: fetal glucose transport is diminished in lung but spared in brain. Pediatr Res 31:59-63, 1991
15. Simmons RA, Flozak AS, Ogata ES: Glucose regulates Glut 1 function and expression in fetal rat lung and muscle in vitro. Endocrinology 132:2312-2318, 1993
16. Simmons RA, Templeton L: IUGR leads to apoptosis and decreased proliferation of β-cells of diabetic animals (Abstract). Pediatr Res 45:357A, 1999
17. Simmons RA, Templeton LJ, Gertz SJ: Intrauterine growth retardation leads to type II diabetes in adulthood in the rat. Diabetes 50:2279-2286, 2001
18. Gerich JE: The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired sensitivity. Endocr Rev 19:491-503, 1998
19. Scaglia L, Cahill CJ, Finegood DT, Bonner-Weir S: Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 138:1736-1741, 1997
20. Bonner-Weir S: Perspective: postnatal pancreatic beta cell growth. Endocrinology 141:1926-1929, 2000
21. Kieffer TJ, Habener JF: The glucagon-like peptides. Endocr Rev 20:876-913, 1999
22. Edvell A, Lindstrom P: Initiation of increased pancreatic islet growth in young normoglycemic mice (Umea +/?). Endocrinology 140:778-783, 1999
23. Buteau J, Roduit R, Susini S, Prentki M: Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells. Diabetologia 42:856-864, 1999
24. Wang Q, Brubaker PL: Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice. Diabetologia 45:1263-1273, 2002
25. Rolin B, Larsen MO, Gotfredsen CF, Deacon CF, Carr RD, Wilken M, Knudsen LB: The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases beta-cell mass in diabetic mice. Am J Physiol Endocrinol Metab 283:E745-E752, 2002
26. Tourrel C, Bailbe D, Lacorne M, Meile MJ, Kergoat M, Portha B: Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4. Diabetes 51:1443-1452, 2002
27. Xu G, Stoffers DA, Habener JF, Bonner-Weir S: Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48:2270-2276, 1999
28. Stoffers DA, Kieffer TJ, Hussain MA, Drucker DJ, Bonner-Weir S, Habener JP, Egan JM: Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 49:741-748, 2000
29. Edlund H: Transcribing pancreas. Diabetes 47:1817-1823, 1998
30. Sharma A, Zangen DH, Reitz P, Taneja M, Lissauer ME, Miller CP, Weir GC, Habener JF, Bonner-Weir S: The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes 48:507-513, 1999
31. Kushner JA, Ye J, Schubert M, Burks DJ, Dow MA, Flint CL, Dutta S, Wright CV, Montminy MR, White MF: Pdx1 restores beta cell function in Irs2 knockout mice. J Clin Invest 109:1193-1201, 2002
32. Simmons RA, Desai BM, Ng D, Stoffers DA: Ex-4 normalizes β cell mass in the IUGR rat (Abstract). In NIH Workshop: B-cell Biology in the 21st Century. Bethesda, MD, 2001
33. Lane RH, Flozak AS, Simmons RA: Measurement of GLUT mRNA in liver of fetal and neonatal rats using a novel method of quantitative polymerase chain reaction. Biochem Mol Med 59:192-199, 1996
34. Bonner-Weir S, Deery D, Leahy J, Weir G: Compensatory growth of pancreatic b cells in adult rats after short term glucose infusion. Diabetes 38:49-53, 1989
35. Brissova M, Shiota M, Nicholson WE, Gannon M, Knobel SM, Piston DW, Wright CV, Powers AC: Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion. J Biol Chem 277:11225-11232, 2002
36. Kaung HL: Growth dynamics of pancreatic islet cell populations during fetal and neonatal development of the rat. Dev Dyn 200;163-175, 1994
37. Macfarlane W, Smith S, James R, Clifton A, Doza Y, Cohen P, Docherty K: The p38 reactivating kinase mitogen-activated protein kinase cascade mediates activation of the transcription factor insulin upstream factor 1 and insulin gene transcription by high glucose in pancreatic b-cells. J Biol Chem 272:20936-20944, 1997
38. Raflq I, Kennedy HJ, Rutter GA: Glucose-dependent translocation of insulin promoter factor-1 (IPF-1) between the nuclear periphery and the nucleoplasm of single MIN6 b-cells. J Biol Chem 273:23241-23247, 1998
39. Macfarlane WM, McKinnon CM, Felton-Edkins ZA, Cragg H, James RF, Docherty K: Glucose stimulates translocation of the homeodomain transcription factor PDX1: from the cytoplasm to the nucleus in pancreatic beta-cells. J Biol Chem 274:1011-1016, 1999
40. Ben-Shushan E, Marshak S, Shoshkes M, Cerasi E, Melloul D: A pancreatic beta -cell-specific enhancer in the human PDX-1 gene is regulated by hepatocyte nuclear factor 3beta (HNF-3beta), HNF-1alpha, and SPs transcription factors. J Biol Chem 276:17533-17540, 2001
41. Gerrish K, Gannon M, Shih D, Henderson E, Stoffel M, Wright CV, Stein R: Pancreatic beta cell-specific transcription of the pdx-1 gene: the role of conserved upstream control regions and their hepatic nuclear factor 3beta sites. J Biol Chem 275:3485-3492, 2000
42. Sharma S, Jhala U, Johnson T, Ferreri K, Leonard J, Montminy M: Hormonal regulation of an islet-specific enahancer in the pancreatic homeobox gene STF-1. Mol Cell Bio 17:2598-604, 1997
43. Marshak S, Benshushan E, Shoshkes M, Havin L, Cerasi E, Melloul D: Functional conservation of regulatory elements in the pdx-1 gene: PDX-1 and hepatocyte nuclear factor 3beta transcription factors mediate betacell-specific expression. Mol Cell Biol 20:7583-7590, 2000
44. Farilla L, Hui H, Bertolotto C, Kang E, Bulotta A, Di Mario U, Perfetti R: Glucagon-like Peptide-1 promotes islet cell growth and inhibits apoptosis in zucker diabetic rats. Endocrinology 143:4397-4408, 2002
45. Li Y, Hansotia T, Yusta B, Ris F, Halban PA, Drucker DJ: Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. J Biol Chem 2002